Pharma Firms to Stop Gifts to Doctors: Is Self Regulation the Answer?

            


Details

Case Code : CLMM059
Publication date : 2009
Subject : Marketing Management
Industry : -
Length : 02 Pages
Price : Rs. 100

To download this case click on the button below, and select the case from the list of available cases:

» Marketing Management
Short Case Studies
» Marketing Case Studies**
» Case Studies Collection
» View Detailed Pricing Info

Key words:

India, pharmaceutical company, ban, gifts, incentives, freebies, doctors, medical profession, marketing ethics, promotional expenses, prescribing behavior, Organization of Pharmaceutical Producers of India, Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations 2002

Note

1: This caselet is intended for use only in class discussions.
2: More comprehensive case studies are priced at Rs.200 to Rs.700 (US $5 to US $16) per copy.


 


Abstract: ICMR India ICMR India ICMR India ICMR India RSS Feed

Many pharmaceutical companies in India who are part of The Organization of Pharmaceutical Producers of India (OPPI) announced their intention to stop providing incentives (such as, gifts, cash, travel holidays, etc.) to doctors to influence their prescribing behavior.

Introduction

In January 2007, several pharmaceutical companies in India announced their intention to stop providing incentives (such as, gifts, cash, travel holidays, etc.) to doctors to influence their prescribing behavior. This voluntary code was developed by The Organization of Pharmaceutical Producers of India (OPPI), which represented major domestic and multinational pharmaceutical companies operating in India. The code also urged these companies to desist from making exaggerated claims regarding the benefits of their products. This code was adapted from the guidelines of the Geneva-based International Federation of Pharmaceutical Manufacturers Associations (IFPMA) that regulates international pharmaceutical practices, of which OPPI is a member.


In recent years, pharmaceutical companies throughout the world have been targeted by critics for their marketing practices, particularly, with regard to their transactions with the doctors...

Case Studies on Related Topics

1. "Lipitor: How far should Pfizer push the Pill?"

2. "The Recall of Vioxx"

3. "Race-Specific Drug 'BiDil': Nitromed's Marketing Challenge"


Google